Effect of pretreatment HIV drug resistance on mortality, attrition and viral suppression in patients initiating antiretroviral therapy and genetic transmission network: an observational cohort study in Southwest China

Our study reveals a moderate prevalence of PDR in Southwest China, significantly associated with increased risk of attrition and virologic failure, particularly amongst patients with resistance to efavirenz/nevirapine. Our findings strongly advocate for routine PDR testing prior to ART initiation to guide optimal first-line treatment strategies.

Authors

Institutions

Publication Details

Journal
Journal of Antimicrobial Chemotherapy
Published
2026-02-02
DOI
https://doi.org/10.1093/jac/dkag073
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of pretreatment HIV drug resistance on mortality, attrition and viral suppression in patients initiating antiretroviral therapy and genetic transmission network: an observational cohort study in Southwest China

Lingjie Liao, H H Chen, Shujia Liang, Litai Qin et al.
Journal of Antimicrobial Chemotherapy
HIV/AIDS drug development and treatment
article

Effect of pretreatment HIV drug resistance on mortality, attrition and viral suppression in patients initiating antiretroviral therapy and genetic transmission network: an observational cohort study in Southwest China

Lingjie Liao, H H Chen, Shujia Liang, Litai Qin, Ge Zhong, Yiming Shao, Yuhua Ruan, Jin Chen, Hui Xing, Yi Feng, Guanghua Lan, Yihong Xie, Qiuying Zhu, Jianjun Li
article en

Abstract

Our study reveals a moderate prevalence of PDR in Southwest China, significantly associated with increased risk of attrition and virologic failure, particularly amongst patients with resistance to efavirenz/nevirapine. Our findings strongly advocate for routine PDR testing prior to ART initiation to guide optimal first-line treatment strategies.

Journal of Antimicrobial ChemotherapyVol. 81(3)
Guangxi Medical University (CN), National Center for AIDS/STD Control and Prevention,China CDC (CN), Guangxi Center for Disease Prevention and Control (CN)
Good health and well-being
Openalex Percentile: Top 38%
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.